Trilogy Capital
MRK icon

Trilogy Capital’s Merck MRK Stock Holding History

Trilogy Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.19M Buy
42,574
+2,545
+6% +$352K 0.24% 75
2026
Q2 		$5.14M Sell
40,029
-1,052
-3% -$123K 0.2% 87
2026
Q1 		$4.94M Sell
41,081
-3,154
-7% -$364K 0.22% 73
2025
Q4 		$4.66M Buy
44,235
+977
+2% +$91.7K 0.21% 74
2025
Q3 		$3.63M Sell
43,258
-1,273
-3% -$105K 0.17% 91
2025
Q2 		$3.53M Buy
44,531
+33,904
+319% +$2.69M 0.17% 83
2025
Q1 		$954K Buy
10,627
+458
+5% +$42.8K 0.05% 179
2024
Q4 		$1.01M Sell
10,169
-1,868
-16% -$193K 0.05% 175
2024
Q3 		$1.37M Sell
12,037
-225
-2% -$26.7K 0.07% 165
2024
Q2 		$1.52M Buy
12,262
+6,360
+108% +$819K 0.08% 145
2024
Q1 		$779K Buy
5,902
+3,112
+112% +$384K 0.04% 164
2023
Q4 		$304K Buy
2,790
+437
+19% +$45.4K 0.02% 209
2023
Q3 		$242K Sell
2,353
-986
-30% -$106K 0.02% 235
2023
Q2 		$369K Buy
3,339
+578
+21% +$65.6K 0.02% 198
2023
Q1 		$294K Sell
2,761
-3,221
-54% -$348K 0.02% 219
2022
Q4 		$664K Buy
5,982
+2,334
+64% +$239K 0.05% 146
2022
Q3 		$314K Buy
3,648
+155
+4% +$13.8K 0.03% 147
2022
Q2 		$318K Buy
3,493
+285
+9% +$25.3K 0.03% 133
2022
Q1 		$263K Buy
+3,208
New +$253K 0.02% 152
2019
Q1 		– Sell
-10,383
Closed -$757K – 150
2018
Q4 		$757K Sell
10,383
-832
-7% -$58.7K 0.1% 71
2018
Q3 		$759K Sell
11,215
-1,353
-11% -$86.2K 0.09% 75
2018
Q2 		$728K Sell
12,568
-234
-2% -$13.2K 0.1% 60
2018
Q1 		$665K Buy
+12,802
New +$691K 0.1% 66

Other funds holding MRK

Smead Capital Management
Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Quilter Plc
Quilter Plc London, United Kingdom $6.95B AUM 39.67% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Trilogy Capital's MRK Position: Q3 2026 in Review

Trilogy Capital increased its Merck (MRK) stake by 6.4% in Q3 2026, buying an estimated $352K and bringing the position to 42,574 shares worth $6.19M. The position accounts for 0.24% of the portfolio, ranked #75.

Trilogy Capital first reported a position in MRK in Q1 2018 and has held it in 23 quarters since. 1,169 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Trilogy Capital held 42,574 shares of Merck worth $6.19M as of Q3 2026.
  • Trilogy Capital bought 2,545 Merck shares in Q3 2026, an estimated $352K.
  • Merck made up 0.24% of Trilogy Capital's portfolio in Q3 2026, its #75 holding.
  • Trilogy Capital first reported a position in Merck in Q1 2018 and has held it in 23 quarters since.
  • 1,169 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.